|
Κυριακή 13 Δεκεμβρίου 2020
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Effect of Elevated Intracranial Pressure on Amplitudes and Frequency Tuning of Ocular Vestibular Evoked Myogenic Potentials Elicited by Bone...
-
Conditions : Hypothyroidism; Surgery; Head and Neck Cancer; Wound Heal; Laryngeal Cancer; Laryngeal Fistula Intervention : Drug...
-
Introduction to the Special Issue: 15th Symposium on Cochlear Implants in Children No abstract available Relationship Between Objective and ...
-
Your subscribed feeds are not being updated automatically because this setting is turned off. Turn on automatic feed updates You...
-
Interaction of H. pylori with toll-like receptor 2-196 to -174 ins/del polymorphism is associated with gastric cancer susceptibility in sout...
-
Turkey's "Second Invasion" of Cyprus: Illegal Drilling in Eastern Mediterranean by Uzay Bulut June 6, 2019 at 4:00 am https:/...
-
Abstract Dissolution is an important property that influences nanoparticle abundance and biological responses, and often becomes a critica...
-
Consent and Autonomy in the Genomics Era Abstract Purpose of Review Genomic tests offer increased opportunity for diagnosis, but their outpu...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου